AAAAAA

   
Results: 1-9 |
Results: 9
RECOMMENDATIONS FROM THE NATIONAL MULTIPLE-SCLEROSIS SOCIETY CLINICALOUTCOMES ASSESSMENT TASK-FORCE
Authors: RUDICK R ANTEL J CONFAVREUX C CUTTER G ELLISON G FISCHER J LUBLIN F MILLER A PETKAU J RAO S REINGOLD S SYNDULKO K THOMPSON A WALLENBERG J WEINSHENKER B WILLOUGHBY E
Citation: R. Rudick et al., RECOMMENDATIONS FROM THE NATIONAL MULTIPLE-SCLEROSIS SOCIETY CLINICALOUTCOMES ASSESSMENT TASK-FORCE, Annals of neurology, 42(3), 1997, pp. 379-382
COPING WITH A DIAGNOSIS OF MULTIPLE-SCLEROSIS
Authors: SULLIVAN MJL MIKAIL S WEINSHENKER B
Citation: Mjl. Sullivan et al., COPING WITH A DIAGNOSIS OF MULTIPLE-SCLEROSIS, Canadian journal of behavioural science, 29(4), 1997, pp. 249-256
CLINICAL OUTCOMES ASSESSMENT IN MULTIPLE-SCLEROSIS
Authors: RUDICK R ANTEL J CONFAVREUX C CUTTER G ELLISON G FISCHER J LUBLIN F MILLER A PETKAU J RAO S REINGOLD S SYNDULKO K THOMPSON A WALLENBERG J WEINSHENKER B WILLOUGHBY E
Citation: R. Rudick et al., CLINICAL OUTCOMES ASSESSMENT IN MULTIPLE-SCLEROSIS, Annals of neurology, 40(3), 1996, pp. 469-479
NEUTRALIZING ANTIBODIES DURING TREATMENT OF MULTIPLE-SCLEROSIS WITH INTERFERON BETA-1B - EXPERIENCE DURING THE FIRST 3 YEARS
Authors: DUQUETTE P GIRARD M DUBOIS R KOBLER RL LUBLIN F KELLEY L FRANCIS GS FREEDMAN M GREENSTEIN JI MISHRA B DELILLIO N WHITAKER J LAYTON B SIBLEY WA LAGUNA J KRIKAWA J PATY DW OGER JJ KASTRUKOFF LF MORRISON W NELSON J GOODIN D MASSA SM GUTTERIDGE E ARNASON BGW NORONHA A REDER AT MARTIA R EBERS GC RICE GPA LESAUX J JOHNSON KP PANITCH HS BEVER CT CONWAY K LI DKB TANTON EL ZHAO GJ FLAK B RIDDEBOUGH A COVER K RHODES B COOK A SMITH K COSTLEY L RENNEBERG S SHAW T GENTON M VANDENNOORT S WEINSHENKER B WEISS W REINGOLD S TAYLOR W WALLENBERG JC BEDELL L SIBLEY WA EBERS GC LUBLIN FD PATY DW REDER AT
Citation: P. Duquette et al., NEUTRALIZING ANTIBODIES DURING TREATMENT OF MULTIPLE-SCLEROSIS WITH INTERFERON BETA-1B - EXPERIENCE DURING THE FIRST 3 YEARS, Neurology, 47(4), 1996, pp. 889-894
ISOMETRIC MUSCLE STRENGTH MEASUREMENTS IN A MULTIPLE-SCLEROSIS TREATMENT TRIAL - COMPARISON WITH THE CLINICAL EXAMINATION
Authors: NOSEWORTHY JH RODRIGUEZ M WEINSHENKER B STOLPSMITH KA WEIS J JOHNSON M PETTERSON TM FERGUSON JA OBRIEN PC AN KN
Citation: Jh. Noseworthy et al., ISOMETRIC MUSCLE STRENGTH MEASUREMENTS IN A MULTIPLE-SCLEROSIS TREATMENT TRIAL - COMPARISON WITH THE CLINICAL EXAMINATION, Neurology, 46(2), 1996, pp. 3094-3094
SCREENING FOR MAJOR DEPRESSION IN THE EARLY STAGES OF MULTIPLE-SCLEROSIS
Authors: SULLIVAN MJL WEINSHENKER B MIKAIL S BISHOP SR
Citation: Mjl. Sullivan et al., SCREENING FOR MAJOR DEPRESSION IN THE EARLY STAGES OF MULTIPLE-SCLEROSIS, Canadian journal of neurological sciences, 22(3), 1995, pp. 228-231
INTERFERON BETA-1B IN THE TREATMENT OF MULTIPLE-SCLEROSIS - FINAL OUTCOME OF THE RANDOMIZED CONTROLLED TRIAL
Authors: DUQUETTE P DESPAULT L KNOBLER RL LUBLIN FD KELLEY L FRANCIS GS FREEDMAN M LAPIERRE Y GREENSTEIN JI MISHRA B DELILLIO N WHITAKER J LAYTON B SIBLEY WA LAGUNA J KRIKAWA J PATY DW OGER JJ KASTRUKOFF LF MORRISON W NELSON J GOODIN D MASSA SM GUTTERIDGE E ARNASON BGW NORONHA A REDER AT MARTIA R EBERS GC RICE GPA LESAUX J JOHNSON KP PANITCH HS BEVER CT CONWAY K LI DKB TANTON EL ZHAO GJ FLAK B RIDDEHOUGH A COVER K RHODES B COOK A SMITH K COSTLEY L RENNEBERG S SHAW T GENTON M VANDENNOORT S WEINSHENKER B WEISS W REINGOLD S TAYLOR W WALLENBERG JC BEDELL L
Citation: P. Duquette et al., INTERFERON BETA-1B IN THE TREATMENT OF MULTIPLE-SCLEROSIS - FINAL OUTCOME OF THE RANDOMIZED CONTROLLED TRIAL, Neurology, 45(7), 1995, pp. 1277-1285
INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: DUQUETTE P GIRARD M DESPAULT L DUBOIS R KNOBLER RL LUBLIN FD KELLEY L FRANCIS GS LAPIERRE Y ANTEL J FREEDMAN M HUM S GREENSTEIN JI MISHRA B MULDOON J WHITAKER JN EVANS BK LAYTON B SIBLEY WA LAGUNA J KRIKAWA J PATY DW OGER JJ KASTRUKOFF LF MOORE GRW HASHIMOTO SA MORRISON W NELSON J GOODIN DS MASSA SM GUTTERIDGE E ARNASON BGW NORONHA A REDER AT MARTIA R EBERS GC RICE GPA LESAUX J JOHNSON KP PANITCH HS BEVER CT CONWAY K WALLENBERG JC BEDELL L VANDENNOORT S WEINSHENKER B WEISS W REINGOLD S PACHNER A TAYLOR W
Citation: P. Duquette et al., INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Neurology, 43(4), 1993, pp. 655-661
INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS .2. MRI ANALYSIS RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: PATY DW LI DKB DUQUETTE P GIRARD M DESPAULT L DUBOIS R KNOBLER RL LUBLIN FD KELLEY L FRANCIS GS LAPIERRE Y ANTEL J FREEDMAN M HUM S GREENSTEIN JI MISHRA B MULDOON J WHITAKER JN EVANS BK LAYTON B SIBLEY WA LAGUNA J KRIKAWA J PATY DW OGER JJ KASTRUKOFF LF MOORE GRW HASHIMOTO SA MORRISON W NELSON J GOODIN DS MASSA SM GUTTERIDGE E ARNASON BGW NORONHA A REDER AT MARTIA R EBERS GC RICE GPA LESAUX J JOHNSON KP PANITCH HS BEVER CT CONWAY K WALLENBERG JC BEDELL L VANDENNOORT S WEINSHENKER B WEISS W REINGOLD S PACHNER A TAYLOR W
Citation: Dw. Paty et al., INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS .2. MRI ANALYSIS RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Neurology, 43(4), 1993, pp. 662-667
Risultati: 1-9 |